be_ixf;ym_202512 d_19; ct_50

Latest Insights on HL

If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases. Gene Editing: The Cure for Every Disease? November 2, 2017 by Ian Dyer Investment Opportunities If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases.
Friday is a big day for the stock market. That’s when we see the monthly employment report. That report almost always creates volatility. Employment Sets Up a Decline on Friday November 2, 2017 by Michael Carr Stocks Friday is a big day for the stock market. That’s when we see the monthly employment report. That report almost always creates volatility.
This is one of the best times of the year to jump into the stock market. And today, I’ll share with you a sector’s prime season that's about to start. The Prime Season for Investing Is Here October 30, 2017 by Chad Shoop Trading Strategies This is one of the best times of the year to jump into the stock market. And today, I’ll share with you a sector’s prime season that's about to start.
You would think AT&T would have learned its lessons by now. But once again, we find a tech company clinging to the status quo. AT&T Is in a World of Hurt October 25, 2017 by Joseph Hargett Stocks You would think AT&T would have learned its lessons by now. But once again, we find a tech company clinging to the status quo.
No Year-end ‘Window Dressing’ Needed – Our Core Strategy Gains of 2017 October 25, 2017 by Optin Wall Street Front Runner Since last month’s update (9/27/17), we closed eight more trades in Wall Street Front Runner. Six “core” trades from the S&P 600: Axcelis Technologies Inc. (NASD: ACLS) … +4.8% NMI Holdings Inc. (NASD: NMIH) … +1.5% Pacific Premier Bancorp Inc. (NASD: PPBI) …     +0.0% Photronics Inc. (NASD: PLAB) … -3.7% Par Pacific Holdings Inc. (NYSE: PARR) … -5.3% […]

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving the 238% gain after I bought your recommendation in Sept. 2019! This week (July 21, 2020) will be my 1 year anniversary with your amazing team … thanks for the life-changing work you all do! Between all your services, 14 triple-digit gains, the greatest at 358%!"

- Matt

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

Share This